Andrew Miller, Ph.D.
Board Member
Kyverna Therapeutics, Inc. (KYTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Miller, Ph.D.
Andrew Miller, Ph.D. is recorded as Board Member at Kyverna Therapeutics, Inc. (KYTX). Kyverna Therapeutics, Inc. reported in an 8-K filed February 24, 2026 that Andrew Miller, Ph.D. was appointed Class III director, effective February 24, 2026.
“On February 24, 2026, the board of directors (the “Board”) of Kyverna Therapeutics, Inc. (the “Company”) appointed Andrew Miller, Ph.D. as a Class III director of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kyverna Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Greg Martini CFO
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Marc Grasso, M.D. CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.